Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B

Journal of Clinical Microbiology

Volumn 49, Issue 8, 2011, Pages 2933-2941

  Darkoh, Charles ^a,c   Kaplan, Heidi B ^a,b   DuPont, Herbert L ^a,b,c,d,e  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d ST LUKE S EPISCOPAL HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUCOSYLTRANSFERASE; URIDINE DIPHOSPHATE GLUCOSE;

ARTICLE; BINDING AFFINITY; CDIFFTOX ACTIVITY ASSAY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; NONHUMAN; PH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TEMPERATURE; TOXIN ANALYSIS;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; FECES; GLUCOSYLTRANSFERASES; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; SENSITIVITY AND SPECIFICITY; TEMPERATURE; URIDINE DIPHOSPHATE GLUCOSE;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 79960953643     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00037-11     Document Type: Article

References (59)

1. Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234:179-186.
2. Barbut, F., et al. 1994. Evaluation of a rapid enzyme immunoassay for the detection of Clostridium difficile in stools. Eur. J. Clin. Microbiol. Infect. Dis. 13:277-278.
3. Bartlett, J. G. 1992. Antibiotic-associated diarrhea. Clin. Infect. Dis. 15:573-581.
4. Bartlett, J. G. 2002. Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 346:334-339.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Breton, C., L. Snajdrova, C. Jeanneau, J. Koca, and A. Imberty. 2006. Structures and mechanisms of glycosyltransferases. Glycobiology 16:29R-37R.
7. Campbell, J. A., G. J. Davies, V. V. Bulone, and B. Henrissat. 1998. A classification of nucleotide-diphospho-sugar glycosyltransferases based on amino acid sequence similarities. Biochem. J. 329:719.
8. Choy, F. Y., and R. G. Davidson. 1980. Gaucher's disease. II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues. Pediatr. Res. 14:54-59.
9. Ciesla, W. P., Jr., and D. A. Bobak. 1998. Clostridium difficile toxins A and B are cation-dependent UDP-glucose hydrolases with differing catalytic activities. J. Biol. Chem. 273:16021-16026.
10. Delmee, M. 2001. Laboratory diagnosis of Clostridium difficile disease. Clin. Microbiol. Infect. 7:411-416.
11. Delmee, M., T. Mackey, and A. Hamitou. 1992. Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools. Eur. J. Clin. Microbiol. Infect. Dis. 11:246-249.
12. Depitre, C., V. Avesani, M. Delmee, and G. Corthier. 1993. Detection of Clostridium difficile toxins in stools. Comparison between a new enzyme immunoassay for toxin A and other routine tests. Gastroenterol. Clin. Biol. 17:283-286.
13. Dillon, S. T., et al. 1995. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect. Immun. 63:1421-1426.
14. Dingle, T., et al. 2008. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology 18:698-706.
15. Dowling, R. H. 1973. The enterohepatic circulation of bile acids as they relate to lipid disorders. J. Clin. Pathol. Suppl. (Assoc. Clin. Pathol.) 5:59-67.
16. Egerer, M., T. Giesemann, T. Jank, K. J. Satchell, and K. Aktories. 2007. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J. Biol. Chem. 282:25314-25321.
17. Elder, G., C. H. Gray, and D. C. Nicholson. 1972. Bile pigment fate in gastrointestinal tract. Semin. Hematol. 9:71-89.
18. Elliott, B., B. J. Chang, C. L. Golledge, and T. V. Riley. 2007. Clostridium difficile-associated diarrhoea. Intern. Med. J. 37:561-568.
19. Feltis, B. A., et al. 2000. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes. Shock 14:629-634.
20. Gasteiger, E., et al. 2005. Protein identification and analysis tools on the ExPASy server. In J. M. Walker (ed.), The proteomics protocols handbook. Humana Press, Totowa, NJ.
21. Genth, H., S. C. Dreger, J. Huelsenbeck, and I. Just. 2008. Clostridium difficile toxins: more than mere inhibitors of Rho proteins. Int. J. Biochem. Cell Biol. 40:592-597.
22. Geric, B., M. Rupnik, D. N. Gerding, M. Grabnar, and S. Johnson. 2004. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J. Med. Microbiol. 53:887-894.
23. Gonda, D. K., et al. 1989. Universality and structure of the N-end rule. J. Biol. Chem. 264:16700-16712.
24. Grabowski, G. A., S. Gatt, J. Kruse, and R. J. Desnick. 1984. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites. Arch. Biochem. Biophys. 231:144-157.
25. Guruprasad, K., B. V. Reddy, and M. W. Pandit. 1990. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. 4:155-161.
26. Ho, J. G., A. Greco, M. Rupnik, and K. K. Ng. 2005. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. U. S. A. 102:18373-18378.
27. Hofmann, F., C. Busch, U. Prepens, I. Just, and K. Aktories. 1997. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 272:11074-11078.
28. Holleran, W. M., et al. 1992. Beta-glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation. J. Lipid Res. 33:1201-1209.
29. Just, I., and R. Gerhard. 2004. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152:23-47.
30. Just, I., et al. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500-503.
31. Just, I., et al. 1995. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270:13932-13936.
32. Khan, M. S., B. K. Sridhar, and A. Srinatha. 2010. Development and evaluation of pH-dependent micro beads for colon targeting. Indian J. Pharm. Sci. 72:18-23.
33. Kuehne, S. A., et al. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713.
34. Lanis, J. M., S. Barua, and J. D. Ballard. 2010. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS Pathog. 6:1001061.
35. Loo, V. G., et al. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449.
36. Lyerly, D. M., D. E. Lockwood, S. H. Richardson, and T. D. Wilkins. 1982. Biological activities of toxins A and B of Clostridium difficile. Infect. Immun. 35:1147-1150.
37. Lyerly, D. M., K. E. Saum, D. K. MacDonald, and T. D. Wilkins. 1985. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47:349-352.
38. McDonald, L. C., et al. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
39. Meador, J., III, and R. K. Tweten. 1988. Purification and characterization of toxin B from Clostridium difficile. Infect. Immun. 56:1708-1714.
40. Monte, M. J., J. J. Marin, A. Antelo, and J. Vazquez-Tato. 2009. Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol. 15:804-816.
41. Muto, C. A., et al. 2005. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect. Control Hosp. Epidemiol. 26:273-280.
42. Northfield, T. C., and I. McColl. 1973. Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. Gut 14:513-518.
43. Peters, S. P., P. Coyle, and R. H. Glew. 1976. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate. Arch. Biochem. Biophys. 175:569-582.
44. Pfeifer, G., et al. 2003. Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J. Biol. Chem. 278:44535-44541.
45. Poley, J. R., and A. F. Hofmann. 1976. Role of fat maldigestion in pathogenesis of steatorrhea in ileal resection. Fat digestion after two sequential test meals with and without cholestyramine. Gastroenterology 71:38-44.
46. Poutanen, S. M., and A. E. Simor. 2004. Clostridium difficile-associated diarrhea in adults. CMAJ 171:51-58.
47. Radominska-Pandya, A., P. J. Czernik, J. M. Little, E. Battaglia, and P. I. Mackenzie. 1999. Structural and functional studies of UDP-glucuronosyl- transferases. Drug Metab. Rev. 31:817-899.
48. Reineke, J., et al. 2007. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446:415-419. (Pubitemid 46474600)
49. Rupnik, M., J. S. Brazier, B. I. Duerden, M. Grabnar, and S. L. Stubbs. 2001. Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 147:439-447.
50. Rupnik, M., S. Pabst, C. von Eichel-Streiber, H. Urlaub, and H. D. Soling. 2005. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151:199-208.
51. Sambrook, J., and D. W. Russell (ed.). 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
52. Sebaihia, M., et al. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786.
53. Shikita, M., J. W. Fahey, T. R. Golden, W. D. Holtzclaw, and P. Talalay. 1999. An unusual case of 'uncompetitive activation' by ascorbic acid: purification and kinetic properties of a myrosinase from Raphanus sativus seedlings. Biochem. J. 341:725-732.
54. Sullivan, N. M., S. Pellett, and T. D. Wilkins. 1982. Purification and characterization of toxins A and B of Clostridium difficile. Infect. Immun. 35:1032-1040.
55. Tobias, J. W., T. E. Shrader, G. Rocap, and A. Varshavsky. 1991. The N-end rule in bacteria. Science 254:1374-1377. (Pubitemid 21917472)
56. von Eichel-Streiber, C., P. Boquet, M. Sauerborn, and M. Thelestam. 1996. Large clostridial cytotoxins - a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol. 4:375-382. (Pubitemid 26325127)
57. von Eichel-Streiber, C., U. Harperath, D. Bosse, and U. Hadding. 1987. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. Microb. Pathog. 2:307-318.
58. Voth, D. E., and J. D. Ballard. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
59. Warny, M., et al. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084. (Pubitemid 41338761)